卵胞浆内精子注射
卵母细胞
男科
玻璃化
胚胎移植
活产
人类受精
卵母细胞冷冻保存
妊娠率
妇科
低温保存
怀孕
胚胎
医学
生物
不育
保持生育能力
生育率
人口
解剖
环境卫生
细胞生物学
遗传学
作者
Zhe Jing,Jun Zhang,Shiling Chen,Weiqing Zhang,Chen Luo,Xingyu Zhou,Xin Chen,Zhuolin Qiu,Huixi Li,Xiaomin Wu
出处
期刊:PubMed
日期:2019-07-30
卷期号:39 (7): 766-771
被引量:1
标识
DOI:10.12122/j.issn.1673-4254.2019.07.03
摘要
To explore the causes of oocyte vitrification and its application in assisted reproduction.We retrospectively analyzed the data of 26 patients with 27 cycles of oocyte vitrification cryopreservation undergoing intracytoplasmic sperm injection (ICSI) and embryo transfer between January, 2008 and October, 2018. The causes of oocyte vitrification and the outcomes of ICSI and clinical pregnancy were analyzed.The causes of oocytes vitrification included mainly azoospermia or severe spermatogenesis disorder of the husband, failure to obtain sperms from the husband, failure of the husband to be present on the day of oocyte retrieval and acute diseases of the husband to not allow sperm collection. A total of 274 oocytes were frozen in 27 oocyte retrieval cycles, and 217 eggs were thawed in 19 cycles with a survival rate of 81.11% (176/217). The normal fertilization rate, cleavage rate and high-quality embryo rate was 74.81% (98/131), 89.80% (88/98) and 36.73% (36/98), respectively. Fifteen patients underwent embryo transfer, and the clinical pregnancy rate and live birth rate was 53.33% (8/15) and 33.33% (5/15), respectively. Compared with patients below 35 years of age, the patients aged above 35 years had significantly lower oocyte survival rate after thawing (82.76% vs 74.42%, P=0.211), clinical pregnancy rate (77.78% vs 16.67%, P=0.041) and live birth rate (55.56% vs 0, P=0.044).Oocytes vitrification can be used as a remedy for infertile couples who fail to provide sperms due to male factors on the day of oocyte retrieval. Vitrification of the oocytes does not significantly affect the fertilization rate or the clinical pregnancy rate. The survival rate of the thawed oocytes is related to the age of the wife, and an age younger than 35 years can be optimal for achieving favorable clinical pregnancy outcomes after oocyte vitrification.
科研通智能强力驱动
Strongly Powered by AbleSci AI